Summary

Japan has a significant and growing prevalence of diabetes. The aging population, along with lifestyle changes, contributes to an increasing number of individuals with diabetes. The high prevalence of diabetes is a primary driver for the demand for blood glucose monitoring devices. Japan has one of the world's oldest populations, and diabetes is more prevalent among older individuals. As the population ages, there is a higher likelihood of diabetes diagnosis and management, leading to an increased need for blood glucose monitoring devices among the elderly. Japan places a strong emphasis on preventive healthcare measures. The importance of early detection and management of chronic conditions, including diabetes, contributes to the demand for blood glucose monitoring devices as part of preventive care strategies. There is a focus on patient education and awareness programs in Japan. These initiatives aim to inform individuals about the importance of regular blood glucose monitoring, early detection of diabetes, and the role of monitoring devices in disease management. Similar to global trends, Japan has been experiencing rising obesity rates. The correlation between obesity and diabetes contributes to an increased need for effective blood glucose monitoring among individuals at risk or diagnosed with diabetes. There is a cultural emphasis on health and well-being in Japan. This cultural mindset encourages individuals to actively manage their health, contributing to a positive environment for the adoption of blood glucose monitoring devices. Japan's economic stability contributes to the affordability of healthcare services and devices. As individuals can afford healthcare products, there is a broader market for blood glucose monitoring devices, ensuring accessibility for a larger segment of the population. Diabetes is a major economic burden in Japan. In 2021, the economic burden of diabetes was estimated to be $40 billion, or 1.3% of Japan's GDP. This is expected to increase to $77 billion by 2030, or 2.1% of Japan's GDP.

According to the research report "Japan Blood Glucose Monitoring Devices Market Overview, 2028," published by Bonafide Research, the Japan Blood Glucose Monitoring Devices market is expected to reach market size of more than USD 1 Billion by 2028. Diabetes has emerged as a global epidemic japan has around 11 million people with diabetes, According to IDF 2021 data. Blood glucose monitoring devices are increasingly integrated with digital health platforms, mobile applications, and electronic health records. This integration allows for seamless data tracking, analysis, and sharing between individuals and their healthcare providers, enhancing overall diabetes management. Blood glucose monitoring functionalities are being integrated into wearable devices such as smartwatches and fitness trackers. This trend aligns with the growing popularity of wearable technologies, providing users with continuous health monitoring and real-time data insights. Manufacturers are placing emphasis on designing blood glucose monitoring devices that are user-friendly, with intuitive interfaces, easy-to-read displays, and simplified user experiences. This trend is aimed at improving overall user adherence and engagement. The adoption of telehealth services, including remote patient monitoring for chronic conditions like diabetes, has increased. Blood glucose monitoring devices that support remote monitoring align with the trend toward virtual healthcare consultations and services. The integration of artificial intelligence (AI) and machine learning in blood glucose monitoring devices is on the rise. AI algorithms can analyze glucose data patterns, provide predictive insights, and assist in personalized diabetes management strategies. There is a growing trend toward patient empowerment and self-care in diabetes management. Blood glucose monitoring devices are designed to empower individuals to take an active role in monitoring and managing their condition, fostering a sense of control over their health. Some manufacturers are adopting subscription-based models for their blood glucose monitoring devices, offering ongoing access to digital health services, continuous updates, and personalized insights. This trend aligns with the growing popularity of digital health subscription services.

The market is split into two categories based on product type: continuous blood glucose monitoring devices and self-monitoring devices. The Self-monitoring Devices segment includes traditional blood glucose meters and test strips, which are widely recognized and utilized by individuals with diabetes. These devices offer a user-friendly and accessible solution for regular blood glucose monitoring, allowing individuals to manage their condition effectively in the comfort of their homes. The familiarity and ease of use associated with self-monitoring devices contribute to their widespread adoption among the Japanese population. The Self-monitoring Devices segment includes traditional blood glucose meters and test strips, which are widely recognized and utilized by individuals with diabetes. These devices offer a user-friendly and accessible solution for regular blood glucose monitoring, allowing individuals to manage their condition effectively in the comfort of their homes. The familiarity and ease of use associated with self-monitoring devices contribute to their widespread adoption among the Japanese population. In Japan, where the aging population is significant, self-monitoring devices cater to the needs of individuals with diabetes who may prefer home-based monitoring for convenience and comfort. The prevalence of type 2 diabetes, often managed through regular blood glucose monitoring, further drives the demand for user-friendly self-monitoring devices.

The Diagnostic Centers segment is expected to achieve the highest Compound Annual Growth Rate (CAGR) in the Japan Blood Glucose Monitoring Devices Market. These centers provide specialized testing services, offering a comprehensive and professional approach to blood glucose monitoring. Equipped with skilled healthcare professionals, including pathologists and specialists, diagnostic centers offer expert oversight and interpretation of blood glucose test results, providing individuals with valuable clinical insights. Diagnostic centers in Japan often play a central role in comprehensive health checkup packages, where blood glucose monitoring is a crucial component. The integration of blood glucose monitoring with broader health screenings aligns with the increasing emphasis on preventive healthcare practices. Furthermore, the availability of advanced diagnostic equipment with enhanced capabilities for blood glucose monitoring positions diagnostic centers as hubs for state-of-the-art testing services, contributing to the projected growth in this segment. The convenience and accessibility of diagnostic centers, coupled with their role in offering holistic health assessments, contribute to their attractiveness for individuals seeking thorough and personalized healthcare services. Additionally, collaborations between diagnostic centers and healthcare providers, as well as favorable health insurance coverage, further enhance the appeal of these centers for blood glucose monitoring services.

Recent Developments:
• The Dexcom G6 CGM System's indication has altered in Japan, according to a May 2022 announcement from Terumo. With this new use case, the Dexcom G6 CGM System will be the sole in Japan to offer real-time continuous glucose monitoring (RT-CGM) that is primarily intended for daily blood glucose management without the need for a blood glucose metre.
• The extension of the reimbursement coverage for the FreeStyle Libre system and the continuous glucose monitoring (CGM) system in Japan to cover all diabetics who use insulin at least once a day was approved by the Ministry of Health, Labour, and Welfare in March 2022.

Considered in this report:
• Geography: Japan
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:
• Japan Blood Glucose Monitoring Devices market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product
• Self-monitoring Devices
• Continuous Blood Glucose Monitoring Devices

By End User
• Hospitals
• Home Care
• Diagnostic Centers

By Indication
• Diabetes
• Pregnancy
• Cardiovascular Disorders & Hypertension
• Cancer
• Respiratory Diseases
• Movement Disorders
• Hearing Disorders
• Wound Care
• Other Indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV)

The approach of the report:
This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources.

Intended audience:
This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Blood Glucose Monitoring Devices industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.

ページTOPに戻る

Table of Contents